CLINICAL_TRIALS
trial_result
· 2020-03-10
Clinical Trial Update: Ipilimumab + Temozolomide in Metastatic Melanoma [Phase 2]
Summary
A Phase 2 trial evaluating the combination of ipilimumab and temozolomide in metastatic melanoma has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Melanoma | Phase 2 | Status: COMPLETED | Results posted: 2020-03-10